Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Apremilast with Narrowband UVB in Plaque Psoriasis
NCT02412644Phase 4Completed
- Sponsor
- Psoriasis Treatment Center of Central New Jersey
- Start
- May 2015
- Primary completion
- Jul 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of apremilast in plaque psoriasis, sponsored by Psoriasis Treatment Center of Central New Jersey. Started May 2015; status: completed.
02
Drugs
apremilast
03
Conditions
plaque psoriasis
Beyond the preview
Go deeper on NCT02412644.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02412644.